
Get exclusive money-saving offers and guides
Straight to your inbox
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Atomo Diagnostics Limited is a medical devices business based in Australia. Atomo Diagnostics shares (AT1) are listed on the Australian Securities Exchange (ASX) and all prices are listed in Australian Dollars. Atomo Diagnostics has a trailing 12-month revenue of around $9 million.
Our top pick for
US stocks
Our top pick for
Cheap broker fees
Our top pick for
Long-term investing
52-week range | $0.23 - $0.63 |
---|---|
50-day moving average | $0.2653 |
200-day moving average | $0.3121 |
Target price | N/A |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-0.0164 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Revenue TTM | $9 million |
---|---|
Gross profit TTM | $3.4 million |
Return on assets TTM | -6.24% |
Return on equity TTM | -74.39% |
Profit margin | -105.53% |
Book value | 0.059 |
Market capitalisation | $146.7 million |
TTM: trailing 12 months
We're not expecting Atomo Diagnostics to pay a dividend over the next 12 months.
Atomo Diagnostics Limited researches, designs, develops, manufactures, and sells medical devices for blood-based rapid testing for professional use and self-testing. The company offers AtomoRapid RDT platforms to suit various blood-based lateral flow test assays and are appropriate for a range of applications, including screening for chronic conditions and detection of infectious diseases. Its rapid test devices are used by healthcare professionals and by consumers to screen for a range of diseases and medical conditions, including HIV infection. The company has operations in Europe, Asia, Africa, and Central and South America. Atomo Diagnostics Limited was founded in 2010 and is headquartered in Leichhardt, Australia.
You can now invest as little as 1 cent into Australian, NZ and US shares. Here's why that's a game changer.
Robinhood is set to go public as soon as June. Here's what you need to do to buy in from Australia.
Steps to owning and managing Zebit shares.
Steps to owning and managing CleanSpace shares.
Steps to owning and managing Benz Mining shares.
Steps to owning and managing Top Shelf International shares.
Steps to owning and managing K12 Inc shares from Australia.
Steps to owning and managing 2U Inc shares from Australia.
Steps to owning and managing Chegg Inc shares from Australia.